Northrop Grumman to Participate in Bernstein’s 42nd Annual Strategic Decisions Conference

FALLS CHURCH, Va., May 21, 2026 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) will participate in Bernstein’s 42nd Annual Strategic Decisions Conference on Thursday, May 28. Kathy Warden, chair, chief executive officer and president, will present beginning at 10:00 a.m. Eastern time. The presentation will be webcast live at http://investor.northropgrumman.com.

Northrop Grumman is a leading global aerospace and defense technology company. Our pioneering solutions equip our customers with the capabilities they need to connect and protect the world, and push the boundaries of human exploration across the universe. Driven by a shared purpose to solve our customers’ toughest problems, our employees define possible every day.

Note: Statements to be made at the conference contain or may contain statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “will,” “expect,” “anticipate,” “intend,” “may,” “could,” “should,” “plan,” “strategy,” “project,” “forecast,” “achieve,” “believe,” “estimate,” “guidance,” “outlook,” “trends,” “goals,” “confident,” “on track” and similar expressions generally identify these forward-looking statements. These forward-looking statements speak only as of the date when made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements after the date of the conference, except as required by applicable law. Forward-looking statements are not guarantees of future performance and inherently involve a wide range of risks and uncertainties that are difficult to predict. A discussion of these risks and uncertainties is contained in the Company’s filings with the Securities and Exchange Commission.

Contact: News Bureau
[email protected]

Adam Barr (Investors)
[email protected]

Source: Northrop Grumman Corporation

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BingX TradFi Stocks Daily Volume Surges 700% in Five Days Amid Rising Multi-Asset Trading Demand
• Amaze and third. Partner to Host Exclusive Creator and Brand Dinner Ahead of VidCon 2026
• New Long-Term Data Shows Lebrikizumab Sustains Atopic Dermatitis Clearance With Less Frequent Dosing and Advances Findings from Dr. Philip Werschler of Spokane Dermatology Clinic